Long-term impacts of vaginal birth with mediolateral episiotomy on sexual and pelvic dysfunction and perineal pain

Doğan, Bülent; Gün, İsmet; Özdamar, Özkan; Yılmaz, Ali; Muhçu, Murat

doi:10.1080/14767058.2016.1174998

Cited by 31 publications

(44 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The authors concluded that the CS had no superior effect on postpartum sexual function compared to VD . Although the VD was noted to have a long‐term effect on sexual function in Doğan et al study, such effect was reported to be clinically subtle and did not lead to sexual dysfunction. Similarly, Dabiri et al reported no association between the difference between mode of delivery and postpartum sexual function, there were no statistically significant differences in any of FSFI items.…”

Section: Discussionmentioning

confidence: 92%

Effect of mode of delivery on female sexual function: A cross‐sectional study

Saleh

Hosam

Mohamed

2019

J of Obstet and Gynaecol

View full text Add to dashboard Cite

Aim A growing body of evidence has suggested a significant impact of mode of delivery on female sexual function. In the present study, we aimed to investigate the effect of mode of delivery on postpartum sexual function. Methods We conducted a cross‐sectional study on 684 women during their first year after their first delivery. The sexual function of the included women was assessed using the Arabic version of the Female Sexual Function Index (FSFI). Data analysis was carried out using SPSS version 22 for Microsoft Windows. Results The present study included 684 primiparous women, in which 320 women had a history of vaginal delivery (VD0 and 364 women had a history of Cesarean section (CS). In terms of FSFI items, women with a history of CS had statistically significant higher FSFI total score than women with VD (31.34 ± 3.8 vs 30.23 ± 3.6, respectively; P < 0.001). Moreover, patients with more than 6 months since birth had a statistically significant higher total FSFI score than patients with less than 6 months since birth (30.97 ± 3.5 vs 29.97 ± 3.5, respectively; P < 0.001). However, the difference was clinically subtle. In addition, women who breastfed their babies had statistically significant lower total FSFI score than women who used artificial methods of lactation (29.61 ± 4.2 vs 30.27 ± 3.3, respectively; P < 0.001). Conclusion In conclusion, the present study showed that the mode of delivery was not clinically associated with clinical impairment in sexual function within 1 year after delivery, despite the statistically significant difference. It is recommended that the decision to perform CS should not rely on the fear of the risk of postpartum sexual dysfunction.

show abstract

Section: Discussionmentioning

confidence: 92%

Effect of mode of delivery on female sexual function: A cross‐sectional study

Saleh

Hosam

Mohamed

2019

J of Obstet and Gynaecol

View full text Add to dashboard Cite

show abstract

“…Some authors (Doğan et al, 2017) report impact of the episiotomy on sexual desire, arousal and orgasm even 5 years after the birth. On contrary some stud-ies did not found differences in reasuming sexuality postnatally among women with episiotomy or those with intact perineum (Lagana et al, 2015;Kramna and Vrublova, 2016).…”

Section: Resultsmentioning

confidence: 99%

Zdravje delovno aktivne populacije / Health of the Working-Age Population

Šarabon¹,

Žvanut²

2017

View full text Add to dashboard Cite

“…Moreover, dyspareunia rate around 25% was observed in women who had an episiotomy [17]. Sexual disorders in women with postpartum perineal pain have previously been reported [10,18,19]. In addition, a clinical study showed that 12.8% of the women who underwent episiotomy presented chronic perineal pain at 5 months, related to obstetric and postpartum factors ( i.e.…”

Section: Introductionmentioning

confidence: 93%

“…Perineal pain is a common consequence of episiotomy and affects up to 97% of women on day 1 postpartum [5,6], up to 70% of women at day 7 to 10 postpartum [7][8][9] and may persist until at least 5 months postpartum [10,11]. Pain after perineal wound (apart from episiotomy) are also reported but less studied because of the high variability of the localization and the depth of the tear.…”

Section: Introductionmentioning

confidence: 99%

Ropivacaine 75mg versus placebo in perineal infiltration for analgesic efficacy at mid- and long-term for episiotomy repair in postpartum women- The ROPISIO study: a two-center, randomized, double-blind, placebo-controlled trial.

Cardaillac

Ploteau

Thuaut

et al. 2020

Preprint

View full text Add to dashboard Cite

Background Perineal pain due to episiotomy is commonly reported and can be severe enough to disturb the mother-infant dyad during the postpartum period. Its incidence at day 7 postpartum varies from 63% to 74%. Recent studies have already investigated the analgesic efficacy of perineal infiltration of ropivacaine after episiotomy, but have only focused on the immediate postpartum period (at 24 and 48 hours after birth). Large, adequately powered, multicenter, randomized controlled trials are required to evaluate the impact of ropivacaine infiltration on perineal pain and mid- and long-term quality of life before the widespread use of ropivacaine to prevent perineal pain after episiotomy can be recommended. Methods The ROPISIO study is a two-center, randomized, double-blind, placebo-controlled trial in La Roche sur Yon and Nantes, France. It will involve 272 women with vaginal singleton delivery and mediolateral episiotomy at term (≥ 37 weeks). Perineal infiltration (ropivacaine 75mg or placebo) will be administrated just after vaginal birth and before episiotomy repair. The primary outcome will be the analgesic efficacy at day 7 postpartum (mid-term), defined by the numerical rating scale of pain (ENS NRS) strictly superior to 3/10 on the perineal repair area. Secondary outcomes will be the analgesic efficacy (ENS NRS), the impact of pain on daily behavior, on the quality of life (36-Item Short Form Health Survey), on the occurrence of symptoms of postpartum depression (Edinburgh Postnatal Depression Scale) and on sexuality (Female Sexual Function Index) at 3 and 6 months (long-term) using validated online questionnaires. This study will have 90% power to show approximately 30% relative risk reduction in the incidence of perineal pain at day 7, from 70.0% to 50.0%. Discussion Ropivacaine is a promising candidate drug, inexpensive, easy to administer, and would be suitable to include in the routine management of deliveries in labor ward. This study will investigate if perineal ropivacaine infiltration just after birth can reduce mid- and long-term postpartum pain and increase quality of life in women with mediolateral episiotomy.

show abstract

Long-term impacts of vaginal birth with mediolateral episiotomy on sexual and pelvic dysfunction and perineal pain

Abstract: Vaginal delivery with mediolateral episiotomy is not associated with urinary and/or fecal incontinence and sexual dysfunction but associated with a decreased sexual functioning as well as sexual desire, arousal and orgasm within postpartum five years.

Cited by 31 publications

References 14 publications

Effect of mode of delivery on female sexual function: A cross‐sectional study

Effect of mode of delivery on female sexual function: A cross‐sectional study

Zdravje delovno aktivne populacije / Health of the Working-Age Population

Ropivacaine 75mg versus placebo in perineal infiltration for analgesic efficacy at mid- and long-term for episiotomy repair in postpartum women- The ROPISIO study: a two-center, randomized, double-blind, placebo-controlled trial.

Contact Info

Product

Resources

About